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ABSTRACT 
Li Yao 
Development of Catalytic Asymmetric Allylation of Dienone 
(Under the direction of James P. Morken) 
 
The catalytic allylation of aldehydes, ketones, and imines is a very useful reaction 
for the formation of a new carbon-carbon bond in synthetic organic chemistry. There 
have been several successful reports of catalytic asymmetric reactions that use 
aldehydes as the substrate. However, there have been very few successful examples 
with ketones. Herein, a nickel-catalyzed allylation of dienones with the pinacol ester 
of allylboronic acid is presented. Based on 3,3’-reductive elimination, the relationship 
between the dienone structure and 1,2- and 1,6-regioselectvity has been studied. The 
development of a catalyzed asymmetric 1,2 allylation of dienones is also presented. 
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I. Introduction and background 
Catalytic asymmetric addition of alkyl or allyl groups to unsaturated substrates is 
very important for carbon-carbon bond formation. Conjugate addition is one kind of 
methodology, which is a synthetically important method for the construction of 
complex organic compounds. In the first chapter, previous research in this area will be 
reviewed. In subsequent chapters our contribution to this area will be described. 
A. Previous research in conjugate addition 
There have been several reports on the use of transition-metal catalyst for the 
conjugate addition of organometallics to activated alkenes. In 1997, the Tomioka 
group1 reported that high enantioselectivity in conjugate addition to a,b-unsaturated 
esters can be achieved by using organolithium reagents in the presence of 
stoichiometric amounts of chiral ether 1 or amine 2 ligand (Scheme 1). But the 
requirement of stoichiometric amounts of chiral ligands makes this reaction less 
enantio-efficient. In order to provide truly efficient strategies, developing catalytic 
rather than stoichiometric processes becomes the main challenge. In the 1980’s, the 
Lippard group used catalytic amounts of a Cu-amide complex for the conjugate 
addition; this is the first example. 2 
________________________________ 
1  Asano, Y.; Iida, A.; Tomioka, K. Tetrahedron Lett. 1997, 38, 8973-8976. 
2  Villacorta, G. M.; Rao, C. P.; Lippard, S. J. J. Am. Chem. Soc. 1988, 110, 3175-3182. 
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Scheme 1: Asymmetric conjugate addition of organolithium reagents with 
stoichiometric chiral ligands 
Me
O
OR
R'Li, 1 (R'=Rh) or 2 (R'=Bu)
Toluene, -78oC
Me
O
OR
R'
R'=Ph, 84% ee
R'=Bu, 99% ee
t-Bu OMe
But-
R=
Ph Ph
MeO OMe N
N
H
H
(-)-sparteine (2)1  
 
 
(i) Copper-catalyzed asymmetric conjugate addition of dialkyzinc reagents. 
The first highly enantioselective Cu-catalyzed conjugate addition of dialkylzinc 
reagents to enones was done by the Feringa group3 in 1997, with chiral monodentate 
phosphoramidites as the ligands. The binaphthol-based phosphoramidite ligand shown 
in Scheme 2, can improve the enantioselectivity up to 98%. A more recent example 
was shown by the Leighton group4 in 2004. They developed a new P-chiral phosphine 
bis(sulfonamide) ligand for the Cu-catalyzed enantioselective conjugate addition of 
diethyl zinc to acyclic aliphatic enones with high enantioselectivity (up to 90-95% ee) 
(Scheme 3). 
 
_________________________________________ 
3 Feringa, B.L., Pineschi, M., Arnold, L.A., Imbos, R., de Vries, A. H. M. Angew. Chem., Int. Ed. 
Engl. 1997, 36, 2620-2623 
4 Duncan, A. P.; Leighton, J.L. Org.Lett. 2004, 6, 22, 4117-4119 
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Scheme 2: Cu-catalyzed asymmetric conjugate addition of dialkylzinc reagents to 
cyclic enones. 
O
+ Et2Zn
Cu(OTf)2 (2 mol%)
(S,R,R)-Ligand (4 mol%) 
        toluene, -30oC
O
Me
O
O
P N
Ph
Ph
Me
Me
(S,R,R)-Ligand
   94% 
>98% ee
 
Scheme 3: Cu-catalyzed enantioselective conjugate addition of diethyl zinc to acyclic 
aliphatic enones 
O
CH3 + Et2Zn
1.2 e.q.
Cu(OTf)2 1.5 mol %
   ligand 2.25 mol %
Et2O, RT, 1h
O
CH3
Et
83% yield
94% ee
NH
P
HN
Cy
t-Bu t-Bu
Tf SO2ArF
Ligand:
 
(ii) Catalytic enantioselective conjugate addition of Grignard Reagents. 
Dialkylzinc reagents are quite efficient in catalytic enantioselective conjugate 
addition and they were used instead of Grignard reagents for decades. But, Grignard 
reagents are readily available, all of the alkyl groups of the organometallic compound 
are transferable, and the magnesium enolate products are quite useful. However, 
achieving high enantioslectivity, and avoiding noncatalyzed background reaction, are 
still two challenging problems when using Grignard reagents. 
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In 2006, Alexandre Alexakis5 reported that combining Grignard reagents and 
chiral diaminocarbenes can afford enantioenriched all-carbon quaternary centers with 
the enantioselectivity up to 96% in the copper-catalyzed asymmetric conjugate 
addition of Grignard reagents to cyclic enones. This method is useful for the addition 
of the phenyl group to cyclic enones, a reaction that can not be done with other 
conjugate addition strategies. 
Scheme 4: Conjugate addition of Grignard reagents to cyclic enones 
O
Me
1,2 R-MgBr, Et2O
3% CuOTf2, 4% ImH+
0o or -30oC, 30 min
*
O
R
Me
R=ethyl, butyl, i-propyl, 
     c-hexyl, c-penyl, Ph
72-100% yield
73-96% yield       
 
In 2005, the Feringa group6 used the Josiphos ligands shown in Scheme 5 to 
promote the Cu-catalyzed conjugate addition of EtMgBr to simple unsaturated acyclic 
a,b-unsaturated esters. From the screen in Scheme 5, it can be seen that the esters 
accommodate any group, such as simple methyl, without the requirement of a 
sterically hindered substituent to avoid uncatalyzed 1,2-additions.  
 
 
__________________________________ 
5 Martin, D.; Kehrli, S.; d’Augustin, M.; Clavier, H; Mauduit, M., Alexakis, A. J. Am. Chem. Soc. 
2006, 128, 8416-8417 
6 Lopez F.; Harutyunyan S.R.; Meetsma A.; Minnaard A.J.; Feringa B.L. Angew. Chem., Int. Ed. 
Engl. 2005, 44, 2752-2856 
 
NN
H
t-Bu
Me
Me
Me
PF6
ImH+
HO
5 
Scheme 5: Cu-catalyzed conjugate addition of EtMgBr to a,b-unsaturated esters. 
 
Me
O
Z
EtMgBr, CuBr SMe2 (5%)
Ligand, t-BuOMe, -75 oC
Me
O
Z
Et
   Z       conv (%)       ee (%)
OMe       99               95
OEt         99               90
Oi Pr       80               53
ON
O
99               50
Fe PPh2
PCy2
Me
(R,S)-Josiphos
 
 
(iii) Rhodium-catalyzed asymmetric conjugate addition.  
Rhodium also can be used in the catalyzed asymmetric conjugate addition to give 
the product with high yield and enantioselectivity. In 1998, Hayashi and Miyaura7 
reported that the asymmetric conjugate addition of phenylboronic acid to 
2-cyclohexenone is effective with high enantioselectivity when using a rhodium 
complex as the catalyst (Scheme 6). In 2003, Shuichi Oi and Yoshio Inoue8 reported 
that high enantioselectivity can be achieved in conjugate addition of organosiloxanes 
to a,b-unsaturated carbonyl compounds when catalyzed by a chiral rhodium complex 
(Scheme 7). 
 
 
_________________________________ 
7 Takaya, Y.; Ogasawara, M.; Hayashi, T.; Sakai, M.; Miyaura, N. J. Am.Chem. Soc. 1998, 120, 
5579. 
8 Oi, S.; Taira, A.; Honma, Y.; Inoue, Y. Org. Lett. 2003, 5, 97. 
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Scheme 6: Rhodium-catalyzed asymmetric conjugate addition of aryl- and 
alkenylboronic acid to enones. 
O
PhB(OH)2
  Rh(acac)(C2H4)2
      (3mol% Rh)
(S)-binap (3 mol%)
dioxane/ H2O
100oC
O
Ph
(S)-
97%ee  
 
Scheme 7: Asymmetric 1,4-addition catalyzed by a chiral rhodium complex. 
 
R Si(OR')3 R
1
O
R2
cat. [Rh(cod)(MeCN)2]BF4
   (S)-BINAP
dioxane/ H2O
90oC, 20h
R1
O
R2
R
R=aryl, alkenyl 87~98% ee
54~90% yield  
 
In 2002, Tamio Hayashi9 reported using [Rh(OH)((S )-binap)]2 as the catalyst for 
the conjugate addition of aryltitanium triisopropoxide to unsaturated ketones. This can 
be achieved with high enantioselectivity to give titanium enolates, which can be 
converted into silyl enol ethers (Scheme 8). In 2004, Tamio Hayashi10 used 
organozinc reagents in the rhodium-catalyzed asymmetric 1,4-addition reaction for 
the synthesis of 2-aryl-piperidones with high yield and enantioselectivity (Scheme 9). 
 
 
_______________________________ 
9 Hayashi, T.; Tokunga, N.; Yoshida, K.; Han, J. W. J. Am. Chem. Soc. 2002, 124, 12102. 
10 Shintani, R.; Tokunaga, N.; Doi, H.; Hayashi, T. J. Am. Chem. Soc. 2004, 126, 6240. 
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Scheme 8: Rhodium-catalyzed asymmetric 1,4-addition of aryltitanium reagents. 
 
O OTi(OPr-i)3
Ar
OSiMe3
Ar
ArTi(OPr-i)3
   cyclic and
acyclic enones
[Rh(OH)((S)-binap)]2
     (3 mol % Rh)
THF, 20 oC, 1h
Ar=Ph, 4-FC6H4, 4-MeOC6H4, 2-MeC6H4
LiOPr-i
ClSiMe3
94-99.8% ee
 
 
Scheme 9: Rhodium-catalyzed asymmetric 1,4-addition reaction for the synthesis of 
2-aryl-piperidones. 
N
O
CO2Bn
ArZnCl
       catalytic
[RhCl((R)-binap)]2
THF, 20oC
H2O
N
O
CO2Bn
Ar
87-100% yield
99% ee  
 
 
 
 
B. Conjugate addition of allyl nucleophiles 
The conjugate addition of allyl nucleophiles to activated alkenes is a synthetically 
important method because it forms a new carbon-carbon bond and the product 
contains synthetically useful carbonyl and olefin functional groups.  
This well-known process can be achieved by a variety of methods. The first 
example was reported by Sakurai in 199711. They used allylsilanes as the reagent and 
8 
titanium chloride as the Lewis acid to successfully promote the allylation of 
a,b-enones to give d,e-enones.  
In 1994, Lipshutz reported that an allylic Grignard, CuBr·SMe2, and Me3SiCl 
combination with the ratio of 1:1:1 can give 1,4-adducts with high yields, shown as 
Scheme 10. Shibata and Bada, in 2002, used organotin compound to react with 
tantalum chloride, through transmetalation, to form an active allyltantalum reagent 
which can react with a,b-enones to give conjugate adducts in high yield (Scheme 
11).13  
Scheme 10: Allylic copper species used in catalyzed conjugate allylation of enones 
 
O
MgBr
cat CuBr DMS
 TMS-Cl, THF
         -78oC
O
H
yield 86%  
Scheme 11: Active allyltantalum reagent used in conjugate allylation of enones. 
Me
Me
SnnBu3
+ TaCl5
O R3
R1 R2
CH3CN
O
R2
R3
Me
Me
R1
 
 
 
_______________________________________ 
11 Hosomi, A.; Sakurai, H. J. Am. Chem. Soc., 1977, 99, 1673. 
12 Lipshutz, B. H.; Hackmann, C. J. Org. Chem. 1994, 59, 7437. 
13Shibata, I.; Kano, T.; Kanazawa, N.; Fukuoka, S. Baba, A. Angew. Chem.,Int. Ed. 2002, 41, 
1389. 
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(i) Conjugate addition to enones bearing an auxiliary unit 
As reported by our group in 2007, using Ni and Pd complexes as catalyst, 
conjugate addition of the allyl group to dialkylidene ketones can be achieved with 
high yield (Scheme 12)14. Again, a new stereocenter and a product containing the 
carbonyl and olefin functional groups formed; this has important synthetic utility. 
 
Scheme 12: Catalytic conjugate addition of allyl groups to styryl-activated enones. 
C5H11
O
Ph
10% Ni(COD)2
20% PCy3B(pin)
THF, rt, 4h
C5H11
O
Ph
C5H11
O
Ph
b addition
b' addition
b:b'     88:12
yield    82%  
 
While simple enones and their derivatives, such as esters, amides, imides, and 
nitriles, only give little addition product, the reaction with dialkylidene ketones is 
quite efficient (Scheme 13), as reported by our group in 2007. 14 
 
 
_____________________________________ 
14 Sieber, J.D.; Liu, S.; Morken, J.P. J. Am. Chem. Soc. 2007, 129, 2214-2215. 
10 
Scheme 13: The effect of the auxiliary unit in conjugate allylation. 
Ph
O
Ph
2.5% Pd2(dba)3
   6% PCy3
B(pin)
THF, rt
     1h
Ph
O
Ph
2.5% Pd2(dba)3
6% PCy3
B(pin)
< 5% conversion
THF, rt
    20 h
79% yield
Ph
O
Me
Ph
O
OEt
Ph
O
N O
O
Me
O
Ph
Ph
O
NMe2
Ph
O
SEt
Ph O
OEt
EtO O
Ph
N
auxiliary
 
The results shown in Scheme 13 illustrate that an auxiliary alkene unit actives the 
enone and makes the reaction occur rapidly when an appropriate catalyst is used. Only 
with both of them, can the reaction happen.  
 
(ii) 3,3’- Reductive elimination. 
Some studies on the conjugate addition of allyl groups to activated alkenes have 
already been done and suggest that this kind of reaction proceeds by a mechanism 
involving 3,3’-reductive elimination15,16 from an unsaturated p-allyl complex I, after 
oxidative formation of the derived p-allyl. Computational studies14 also proved what  
_________________________________ 
15 Ariafard, A.; Lin, Z. J. Am. Chem. Soc. 2006, 128, 13010 
16 Hirano, K.; Yorimitsu, H.; Oshima, K. Org. Lett. 2007, 1541 
11 
has been shown in the Scheme 14. 
Scheme 14: The 3,3’ reductive elimination mechanism. 
 
 
 
 
 
 
C. Research goals. 
   Like conjugate addition, catalytic allylation of aldehydes, ketones, and imines is 
also a very useful reaction for the formation of a new carbon-carbon bond in synthetic 
organic chemistry. There are many successful examples of catalytic asymmetric 
reactions using aldehydes as the substrates. However, far fewer successful examples 
are known with ketones, thus revealing the hurdles in chiral tertiary alcohol synthesis. 
In the light of our success using 3,3’ reductive elimination in the conjugate 
allylation of dialkylidene ketones to give high yield and enantioselectivity, a new 
substrate, a,b,g,d-unsaturated ketone, also with an auxiliary unit, was explored to see 
whether this structure will react. 
 
 
 
M
R2
OB(pin)
R1
I
L
R1
O
R2
10% Ni(cod)2
20% ligand
B(pin)
R1
O
R2
1 2
+
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II. Catalytic asymmetric 1,2-allylation of dienones. 
A. Previous research on allylation of carbonyl derivatives. 
In 2004, Patrick J. Walsh17 reported a simple procedure for the catalytic 
asymmetric allylation of ketones, by using tetraallylstannane as the allylating agent 
together with titanium tetraisopropoxide, BINOL and 2-propanol as an additive 
(Scheme 15). A variety of ketone substrates were applied to this reaction with good 
yields (67-99%) and high enantioselectivity (>80%). A subsequent epoxidation was 
introduced that occurred with give high diastereoselectivity. Although high 
enantioselectivity can be achieved in the above example; allystannanes are somewhat 
toxic and catalyst loading is as high as 30 mol%. Allylsilanes are generally a more 
desirable reagent because they are less toxic and more stable than allylstannanes. 
However, allylsilanes are less reactive than allystannanes, which limited their 
synthetic use.  
Scheme 15: Catalytic asymmetric 1,2-allylation of ketones by tetraallylstannane.  
O
Me Me
Me
1) Ti(OiPr)4 (30 mol %)
     BINOL (30 mol %)
     i-PrOH (20equiv)
     Sn(allyl)4 (1.5 equiv)
2) TBHP (1 equiv) Me Me
Me
HO
O
1 diastereomer
84% y., 96% ee  
_________________________________________ 
17 Kim, J.G.; Waltz, K.M.; Garcia, I.F.; Kwiatkowski, D.; Walsh, P.J. J. Am. Chem. Soc. 2004, 
126, 12580-12585. 
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The first catalytic asymmetric allylation with allylsilanes was done in 2002 by the 
Shibasaki group.18 They used allyltrimethoxysilane as the allylsilane reagent and 1-10 
mol % CuCl and TBAT in THF at room temperature to achieve very high yield and 
enantioselectivity (up to 60%) (Scheme 16). In 2005, the Yamamoto group19 further 
developed this asymmetric Sakurai-Hosomi allylation of simple ketones by using the 
complex of AgF and (R)-DIFLUORPHOS in THF. With the addition of 1.0 
equivalent MeOH and 1:1 complex of AgF and (R)-DIFLUORPHOS, high 
enantioselectivity (up to 96%) can be achieved; only the 1,2-addition products were 
observed from conjugate ketones, and high enantioselectivity and diasteroselectivity 
were common (Scheme 18). 
Scheme 16: Catalytic asymmetric 1,2-allylation of ketones by allylsilanes. 
X
R1 R2
1) CuCl-TBAT (1-10 mol %)
     CH2=CHCH2Si(OMe)3 (1.5 euqiv)
             THF, rt
2) H+
X=O, NBn
R1, R2 = aryl, alkyl, H
R1
XH
R2
100% yield
  56% ee
 
Scheme 17: Asymmetric Sakurai-Hosomi allylation of ketones by silver complex. 
Ph
O
Me
Si(OMe)3
(R)-DIFLUORPHOS (5mol%)
                     AgF(5mol%)
          MeOH(1equiv)
THF, -78oC to -40oC
            74% yield
Ph
Me OH
syn/anti = 96 (99%ee)/4  
 
________________________________________ 
18 Yamasaki, S.; Fujii, K; Wada, R; Kanai, M; Shibasaki, M. J. Am. Chem. Soc., 2002, 124, 6536 
-6537. 
19 Wadamoto, M.; Yamamoto, H. J. Am. Chem. Soc., 2005, 127 (42), 14556 -14557. 
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In 2005, the Shibasaki group reported the first catalytic asymmetric allylboration 
of ketones. They used CuF-iPr-DuPHOS (3 mol %) as a chiral catalyst and La(OiPr)3 
(4.5 mol %) as a cocatalyst to achieve enantioselectivity as high as 93% ee. In 2006, 
the Shaus group21 used chiral diols as catalytic promoters of asymmetric allylboration 
reactions without using a metal; this is an environmental-friendly, catalytic 
enantioselective allylboration of ketones. Chiral BINOL-derived diols were used, 
such as 3,3’-Br2-BINOL, and allyldiisopropoxylborane was the nucleophile. Good 
yields (76-93%), high enantioselectivies (er > 98:2), and high diastereoselctivities 
were obtained (Scheme 19). 
Scheme 18: Catalytic asymmetric allylboration of ketone by chiral copper complex. 
 
 
 
Scheme 19: Metal-free catalytic enantioselective allylboration by chiral diols. 
 
_______________________________________________________ 
20 Wada, R.; Oisaki, K.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2004, 126, 8910 -8911. 
21 Lou, S.; Moquist, P. N.; Schaus, S. E. J. Am. Chem. Soc. 2006, 128, 12660.  
 
 
 
 
R
O
R'
+
B
O
O
CuF2 2H2O (3 mol %)
(R,R)-iPr-DuPHOS (6 mol %)
La(OiPr)3 (4.5 mol %)
DMF, -40 oC
R1
R2
R
HO R'
R1 R2
up to 93% ee
R1
O
R2 R4
R3 B
O
O
i-Pr
i-Pr
15mol%
(S)-3,3'-Br2-BINOL
PhCH3; PhCF3
         -35oC
R1
R3R4
R2 OH
76-93% yield
   er      95:5
   dr      98:2
>
>
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B. Catalytic allylation of dienones.  
In this thesis, the catalytic asymmetric allylation of a,b,g,d unsaturated ketones, 
also called dienones, with the pinacol ester of allylboronic acid [allylB(pin)] is 
described; this reaction is based on the 3,3’ reductive elimination that applies to 
similar unsaturated ketones. 
In the presence of Ni(cod)2 and PCy3, an α,β,γ,δ-unsaturated carbonyl electrophile,  
with an aromatic ring in the alkene side reacted by carbonyl addition as the 
predominant reaction pathway (Scheme 20). 
 
 
Scheme 20: Nickel-catalyzed allylation of dienones. 
Ph
O
Me
10% Ni(COD)2
10% PCy3
B(pin)
3.0 eq
THF, 18h, rt
Ph
OH
MePh
HO
Me
+
EZ EE
EZ yield: 85% EZ:EE=5:1  
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(i) Proposed mechanism 
The proposed catalytic cycle for this reaction is shown in Scheme 21. We can see 
that this reaction cycle began with a boron-activated oxidative addition of an enone to 
a nickel catalyst to form the p-allyl complex II (Scheme 20), and then transmetalation 
gave the p-allyl complex III. After that, 3,3’-reductive elimination generated the 
1,2-allylation product and gave the nickel(0) back. 
 
Scheme 21: Proposed catalytic cycle for the Ni-catalyzed 1,2-allylation of dienones 
 
LnNi(0)
R1 R2
O
Ni
R1 R2
ONiL
B(pin)
R1
BO R2NiL
R1 R2
O
B
O
O
Me
Me
Me
Me
R1
OH
R2
L
II
III
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(ii) Development of a catalyzed 1,2-allylation of dienones. 
In order to make this conjugate allylation useful in broad synthesis settings, it 
requires an efficient reaction which should have both high yield and high 
chemo/stereo-selectivity. Thus, we choose (3E, 5E)-6-phenylhexa-3, 5-dien-2-one as 
a substrate to screen a variety of achiral phosphorous ligands and metals, as shown in 
Table 1. 
 
Table 1: Catalyst survey in Ni-catalyzed 1,2-allylation of dienone 
.
Ph Me
Ph
HO Me
O
Ph Me
OH
+
B(pin)
E,Z
E,E
THF, 18h, rt
10% metal
10% Ligand
Ph Me
O
+
1,2 addition
1,4 addition
3.0 eq
 
 
 
 
 
 
 
 
 
Entry Metal Ligand % (1,2) 
[EE:EZ] 
% (1,4)  
1 Ni(COD)2 PPh3 62 ( 10: 1 ) 10 
2 Ni(COD)2 PCy3 84 ( 1:10) < 5 
3 Ni(COD)2 P(NMe2)3 80 ( 1: 1 ) < 5 
4 Ni(COD)2 P(OEt)3 44 (>50:1) 38 
5 Pd2(dba)3 PCy3 30 ( 1: 1 ) < 5 
6 Pd2(dba)2 PPh3 < 5 < 5 
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The result of this screen showed that catalysis with nickel was more effective 
than with palladium (entry 5 and entry 6). Also, the reaction with PCy3 was much 
more effective than with other phosphorous ligands. Clearly, the reaction with nickel 
and PCy3 (entry 2) is the best compared to the other conditions.  
 
 
C. Application of the Ni-catalyzed 1,2-allylation of dienones to other 
substrates. 
A number of this kind of dienone, with the aromatic ring attached to the d 
carbon participate into this 1,2-allylation (Table 2). Surveying substrates shows the 
relationship between product yields and dienone structure. From the results, it is 
postulated that with the aromatic ring at the d carbon, the major products will always 
be the 1,2 adducts. The size of the group adjacent to the carbonyl group also affects 
the yield of 1,2-allylation product. But all of the substrates with alkyl ketone can 
achieve yields around 60~95%. 
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Table 2: Ni-catalyzed allylation of different substrates to give 1,2 adducts 
B(pin)
10 mol% Ni(cod)2
10 mol% PCy3
THF, rt, 18 h
3 equiv
R
O
R
R
Major: 1,2-addition
R
 
entry reactant Major product Yield (%) 
 
 
 
1 
 
Ph
O
Me  
 
Ph
HO Me
 
 
 
70 
 
 
 
2 
 
O
pentylPh  
 
Ph
HO pentyl
 
 
 
 
95 
 
 
 
3. 
 
Ph
O
Me
Me  
Ph
HO
Me
Me
 
 
 
 
55 
 
 
 
4 
 
Ph
O
 
Ph
HO
 
 
 
 
79 
 
 
 
5 
 
Ph
O
Me
Me  
 
Ph
HO
Me
Me
 
 
 
 
90 
 
 
 
6 
 
Ph
O
Me
Me  
 
Ph
OH
Me
Me
 
 
 
 
94 
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D. Ni-catalyzed asymmetric allylation of activated enones. 
With the goal of developing a general catalytic enantioselective allylation of 
ketones, a collection of chiral phosphorous ligands was surveyed in the 1,2-allylation 
reaction. TADDOL-derived phosporamidites, phosphonites, and phosphites were 
initially explored. The results of some of the TADDOL-derived ligands are shown in 
Table 3. 
Most of these phosphoramidites employed gave good yields, indicating that these 
ligands are acceptable in the reaction. A decrease in the size of the amino group in the 
ligand appeares to lower the enantioselectivity (entries 2-6, Table 3). However, 
enlarging the TADDOL-backbone by substituting the phenyl group with 
3,5-dimethylphenyl groups and 3,5-diisopropylphenyl group led to a reduction in ee 
(entry 7 and 8) while substituting with 3,5-di-t-butyl groups led to an inversion in ee 
-73% (entry 9). It is possible that the larger the amino-group and the smaller the aryl 
group or the smaller the amino-group and the larger the aryl group, the higher 
enantioselectivity can be attained. From all of these data, it is easy to see that entry 2, 
entry 3, and entry 9 give the best enantioselectivity, E,Z selectivity, and also good 
yield. 
 
Table 3: Ligand screen in the catalytic asymmetric allylation of ketone 
Ph Me
Ph
HO Me
O
Ph Me
OH
+
B(pin)
5 mol% Ni(cod)2
10 mol% Ligand
1.2 equiv
E,Z E,E
THF, 18h, rt
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entry ligand Yield (%) EZ:EE ee (%) 
 
 
1 
P
O
O
O
O
N
Ph Ph
Ph Ph
Me
Me
Ph
Me
Ph
Me
 
 
 
0 
 
 
n/a 
 
 
n/a 
 
 
2 O
P
OO
OMe
Me
PhPh
PhPh
N
 
 
 
84 
 
 
6:1 
 
 
74 
 
 
3 O
P
OO
OMe
Me
PhPh
PhPh
N
 
 
 
50 
 
 
3.7:1 
 
 
72 
 
 
4 O
P
OO
OMe
Me
PhPh
PhPh
N
 
 
 
38 
 
 
8:1 
 
 
52 
 
 
5 O
P
OO
OMe
Me
PhPh
PhPh
N
 
 
 
73 
 
 
19:1 
 
 
27 
 
 
6 
O
P
OO
OMe
Me
PhPh
PhPh
N
Me
Me
 
 
 
34 
 
 
13:2 
 
 
26 
 
 
7 O
P
OO
OMe
Me
ArAr
ArAr
N
Me
Me
Ar = 3,5-di-methyl  
 
 
30 
 
 
14:1 
 
      
26 
 
     
   8 O
P
OO
OMe
Me
ArAr
ArAr
N
Me
Me
Ar = 3-isopropylphenyl  
 
 
77 
 
 
n/a 
 
 
17 
 
 
9 O
P
OO
OMe
Me
ArAr
ArAr
N
Me
Me
Ar = 3,5-di-t-butylphenyl  
 
 
58 
 
 
14:1 
 
 
-73 
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E. Development of an asymmetric catalytic 1,2-allylation of 
Dienones. 
In order to optimize the yield and enantioselectivty, we chose the 
TADDOL-derivative from entry 9 in Table 3 as the ligand and screened different 
solvents (Table 4). From entry 2, entry 3, and entry 4, we can see that using ethyl 
ether as the solvent can not only increase the yield up to 83% but also increase the EZ 
selectivity, as high as 43:1; THF and toluene can greatly increase the 
enantioselectivity up to around 75%, but no reaction occurred in CH3CN (entry 1). 
Thus, we chose THF and ethyl ether as the solvent to optimize other conditions. 
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Table 4: Solvent effect on the asymmetric Ni-catalyzed 1,2-allylation of dienones 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The reaction temperature also affects the result substantially. From Table 5, at 
temperatures below -76oC conversion is very low, while at -20oC enantioselectivity 
increases a bit but the yield also decreased. While at 0oC and with THF solvent, -80% 
ee can be attained and the yield is as high as 47% (entry 6).  
 
 
Entry Solvent Yield (%) EZ: EE ee (%) of EZ 
1 CH3CN 0 n/a n/a 
2 THF 58 14:1 -73 
3 Ethyl Ether 83 43:1 -57 
4 Toluene 56 17:1 -74 
.
Ph Me
Ph
HO Me
O Ph Me
OH
+
B(pin)
 5 mol% Ni(COD)2
10 mol% Ligand L3
E,Z E,E1.2 equivsolvent,18h, rt
O
P
OO
OMe
Me
Ar
ArAr
N
Me
Me
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Table 5: Other effects on the asymmetric Ni-catalyzed 1,2-allylation of dienone 
 
 
 
 
 
 
 
 
When the amount of metal was increased up to 10%, and the amount of 
allyl-B(pin) was increased up to 3.0 equivalents (entry 7), the yield improved 
dramatically while the enantioselectivity was not affected. But at the lower 
temperature of 10oC (entry 8), the yield decreased while the enantioselectivity did not 
entry AllylB(pin) Metal (mol%) Ligand Solvent 
t 
(h) 
T 
(oC) 
Yield  
(%) EZ/EE 
ee (%) 
of EZ 
1 1.2 5 10 ethyl 
ether 
18 rt 83 43:1 -57 
2 1.2 5 10 
ethyl 
ether 
18 -78 0 n/a n/a 
3 1.2 5 10 
ethyl 
ether 
18 -20 12 >50:1 -76 
4 1.2 5 10 THF 18 rt 58 14:1 -73 
5 1.2 5 10 THF 18 -20 10 7:1 -82 
6 1.2 5 10 THF 18 0 47 >50:1 -80 
7 3.0 10 10 THF 18 rt 96 >>50:1 -70 
8 3.0 10 10 THF 42 10 85 >50:1 -71 
Ph Me
Ph
HO Me
O
Ph Me
OH
+
B(pin)
 Ni(cod)2
 Ligand
E,Z E,E
Solvent, t, T
O
P
OO
OMe
Me
Ar
ArAr
N
Me
Me
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increase much. Thus, we chose the condition shown in entry 7 as the general 
condition for further study. 
F. Application of the asymmetric catalytic 1,2-allylation of 
dienones to different substrates 
A number of dienones with an aromatic ring at the d carbon were examined with 
chiral ligands in this asymmetric 1,2-allylation. As we can see from Table 3, an 
increase in the size of the amino group on the ligand appeared to increase the 
enantioselectivity, so two ligands (entry 2 and entry 3, table 3) were examined with 
each substrate (Table 6). Generally, the ligand with a 3,5-di-t-butyl phenyl ring on the 
TADDOL backbone led to an inverse enantioselectivity (entry 9, table 3), so this 
ligand was also tried in the substrate study. 
For the methyl ketone substrate, the yield was 84%, 65% and 96% when using 
L1, L2 and L3 as the ligand respectively (entries 1-3), while the ee ranged around 
74% (entry 1), 70% (entry 2) and -70% (entry 3). For the phenyl ketone substrate, the 
ee increased up to 93% (entry 4) and 88% (entry 5) for L1 and L2, while it decreased 
down to -54% for L3 (entry 6). However, the yield with all three ligands decreased 
relative to the reaction with the methyl ketone. For the substrate with isopropyl group 
as R2, the ee is 87% (entry 7), 81% (entry 8) and -73% (entry 9).  
Generally, ligand 1 with the seven membered azacycle gives the best 
enantioselectivity, while ligand 3 with 3,5-di-t-butyl aromatic ring on the TADDOL 
backbone gives the highest yield. The reaction of the substrate with a phenyl group 
26 
can achieve the enantioselectivity above 90%, while the yield is just around 50%.  
Table 6: Substrate scope in a Ni-catalytic asymmetric 1,2 allylation of dienones 
 
 
 
 
 
 
 
L1                      L2                       L3  
 
 
 
 
Entry R1 R2 Ligand Yield (%) EZ: EE ee (%) of 
EZ 
1 Ph Me L1 84 6:1 74 
2 Ph Me L2 65 6:1 70 
3 Ph Me L3 96 >50:1 -70 
4 Ph Ph L1 40 3:1 92 
5 Ph Ph L2 41 3:1 88 
6 Ph Ph L3 69 2:1 -54 
7 Ph Isopropyl L1 67 2:1 87 
8 Ph Isopropyl L2 55 >20:1 81 
9 Ph Isopropyl L3 76 6:1 -73 
.
R1 R2
R1
HO R2
O R1 R2
OH
+
B(pin)
   10% Ni(COD)2
   10% Ligand
E,Z E,E
solvent, t, T
3.0 eq.
O
P
OO
OMe
Me
PhPh
PhPh
N
O
P
OO
OMe
Me
PhPh
PhPh
N
O
P
OO
OMe
Me
Ar
ArAr
N
Me
Me
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III. Catalytic enantioselective 1,6-conjugate allylation of dienones. 
A. Previous research on catalytic 1,6-conjugate addition. 
Much progress has been made on catalytic asymmetric 1,4- and 1,2-addition to 
unsaturated carbonyl derivatives as described in Chapter I of this account. However, 
asymmetric 1,6-addition to conjugated systems has not been well-developed. At the 
beginning of this chapter, let us first examine what has already been achieved in the 
area of 1,6-conjugate addition.  
 
(i). Metal-catalytic 1,6-conjugate addition reaction 
Copper salts are an excellent catalyst for conjugate addition of Grignard reagents 
to unsaturated carbonyl compounds22, 23, 24 and there are also several examples of 
1,6-addition of organocopper reagents to a,b,g,d-unsaturated carbonyl derivatives. 
However, 1,6 conjugate addition of aryl Grignard reagents to some 2,4-dienoates 
using copper catalysis faces some difficulty. 
 
____________________________________________________ 
22 Corey, E. J.; Kim, C. U.; Chen, R. H. K.; Takeda, M. J. Am. Chem. Soc. 1972, 94, 4395–4396; 
Corey, E. J.; Boaz, N. W. Tetrahedron Lett. 1985, 26, 6019–6022. 
23 Modi, S. P.; Gardner, J. O.; Milowsky, A.; Wierzba, M.; Forgione, L.; Mazur, P.; Solo, A. J.; 
Duax, W. L.; Galdecki, Z.; Grochulski, P.; Wawrzak, Z. J. Org. Chem. 1989, 54, 2317–2321 
24 Krause, N.;Gerold, A. Angew. Chem., Int. Ed. 1997, 36, 186–204. 
 
28 
In 2005, Urabe25 reported an alternative way to give high 1,6 regioselectivity by 
using iron salts to replace copper reagents as the catalyst, shown by Scheme 22. 
 
Scheme 22: Iron-catalyzed 1,6-conjugate addition to dienoates. 
R1
R2
COY
R3
ArMgBr (1.8 equiv)
  FeCl2 (0.1 equiv)
THF
-45~-35 oC, 3h
H+ R
1
R2
COY
R3
Ar
Y=OEt, NEt2 yield: >70%  
 
Instead of using an iron complex as the catalyst, perfect 1,6-selective addition of 
aryl boronic acids to electron-deficient dienones can also be achieved, by using an 
iridium complex [{Ir(OH)(cod)}2] as the catalyst. 26 
 
Scheme 23: [{Ir(OH)(cod)}2] complex in 1,6 addition of dienones. 
Me
Me
O
+ (PhBO)3
[{Ir(OH)(cod)2)}2]
(5 mol% Ir)
H2O (0.5 equiv)
toluene, 80oC, 3h
Me
Me
O
Ph
Me
Me
O
Ph
+ +
Me
Me
O
Ph
Me Me
O Ph
Me Me
O Ph Ph
a b c
88% a/b/c=93:2:5
0% 2%
 
 
___________________________________________ 
25 Fukuhara K.; Urabe H. Tetrahedron Lett. 2005, 46, 603-606 
26 Nishimura, T.; Yasuhara, Y; Hayashi, T. Angew. Chem. Int. Ed. 2006, 45, 5164-5166 
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(ii). Catalyzed enantioselective 1,6-conjugate addition reaction 
Like what has been shown above, several methodologies have been reported for 
1,6-additions, however, catalyzed asymmetric transformations still have not been 
greatly developed. Recently, there have been two reports in this area. 
The first example of a catalytic enantioselective 1,6-addition was reported by 
Hayashi in 2005 (Scheme 24).27 They used chlorotrimethylsilane as a Lewis acid and 
a rhodium/(S)-binap complex as the catalyst to achieve high enantioselectivity in the 
preparation of a,b-unsaturated ketones with a new stereogenic center; high yield 
(99%) and high enantioselectivity (96% ee) was observed. 
 
Scheme 24: First catalytic asymmetric 1,6-addition 
O
R
R=n-C5H11
+
PhZnCl
1.4 equiv
Me3SiCl (1.5 equiv)
[{RhCl[(S)-binap]}2 (3 mol% Rh)
THF, 20oC, 12h
dil. HCl
O
R
Ph
99% yield
96% ee (R)
    Then, the Feringa group28 reported the first Cu-catalyzed enantioselective 
conjugate addition of simple alkyl Grignard reagents to linear d-substituted 
2,4-dienoates. The b,g-unsaturated 1,6-addition product could be obtained with 
excellent regio- and enantioselectivity by employing the reversed josiphos ligand 
(Scheme 25) at -70oC. 
_______________________________ 
27 Hayashi T; Yamamoto, S; Tokunaga, N. Angew. Chem. Int. Ed.. 2005, 44, 4224-4227 
28 den Hartog, T; Harutyunyan, S.R.; Font D.; Minnaard, A.J.; Feringa, B.L. Angew. Chem. Int. Ed. 
2008, 47, 398-401 
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Scheme 25: First Cu-catalyzed enantioselective conjugate addition to linear 
d-substituted 2,4-dienoates 
Me OEt
O
      EtMgBr
CuBr SMe2, ligand
CH2Cl2,
Me OEt
O
Me
*
OEt
O
+
1,6 1,4
Me Me
-70oC, 24 h
1,6:1,4=  99:1 Conv. 98% 
              95% ee
Fe
Ph2P
Me
Cy2P
Ligand:
    
 
 
In the few examples above, the excellent regioselectivity is limited to specific 
structural features in the substrates. Also, 1,6-conjugate allylation of dienones have 
not been developed. Thus, there is a promising pathway ahead to encourage us to 
continue in this area. 
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B. Discovery of 1,6-allylation during 1,2-allylation of dienones 
   Returning to what has been discovered at the end of Chapter II, the phenyl ketone 
substitute reacted with the yield around 50% for the 1,2-allylation of dienone. Then, 
what was the other 50% of the product? The by-product is the 1,6 conjugate addition 
product, as shown in the Scheme 26 below. 
Scheme 26: Allylation adducts for (2E,4E)-1,5-diphenylpenta-2,4-dien-1-one  
B(pin) Ph Ph
10 mol% Ni(COD)2
10 mol% PCy3
THF, rt, 18 h
3 equiv
Ph
O
Ph
O
Ph Ph
HO
1,6-addition1,2-addition
+
EZ+EE: 47% yield E+Z: 27% yield  
   Our original hypothesis about how the 1,6-conjugate addition occurs is shown 
below (Scheme 27), and is based on the mechanistic studies previously done in our 
lab.  
Scheme 27: Proposed mechanism for the formation of 1,2 and 1,6 adducts 
II
R1 R2
   Ni(cod)2
 ligand
B(pin)
1
2
+
O
R1
BO R2
M
L
R2
OB(pin)
R1 M L
R1
OH
R2
R1 R2
O
1,2 allylation
1,6 allylationIII  
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From the above scheme, it is easy to see how the 1,6-conjugate addition product is 
generated. It appears that this reaction may also proceed though 3, 3’ reductive 
elimination. As shown in Scheme 6, the 1,2- and 1,6- allylation products arise from 
different intermediate bis(allyl) complexes, II or III, respectively.  
As observed from the differences between substrates 1 and 2 (Scheme 28), a 
phenyl ketone is employed, the ratio of 1,6-addition product is much higher than 
when the methyl ketone is used. The reason is probably that when R2 is an aromatic 
ring, the complex III is much more stable, giving more 1,6-addition product. Similar 
to conjugate addition of allyl groups to dialkylidene ketones, the allyl group tended to 
transfer distal to aromatic ring substituent.  
 
 
 
Scheme 28: Difference in the products of two substrates 
 
Ph
O
Me
1,2:1,6 > 50:1
  51% yield
Ph
O
Ph
1,2:1,6 = 43:57
   70% yield
substrate 1 substrate 2
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   In order to improve the regioselectivity of 1,6 addition reaction, it will be good to 
make complex III much more stable than complex II. Thus, the substrate with an 
aliphatic group as 2 and phenyl group as R2 would be a promising substrate to give a 
high ratio of 1,6 addition product.  
As we expected, the major product of nickel-catalyzed allylation of 
(2E,4E)-1-phenylhexa-2,4-dien-1-one was the 1,6-adduct, with the yield as high as 
63% and 1,6:1,2 ratio up to 95:5 (Scheme 29). 
 
 
Scheme 29: Nickel catalyzed allylation of (2E,4E)-1-phenylhexa-2,4-dien-1-one 
Me
O
Ph
10% Ni(COD)2
10% PCy3
B(pin)
3.0 eq
THF, 18h, rt
Me
O
Ph
Me
HO Ph
+
1,2 1,6
1,6 yield: 63%   1,6:1,2=95:5
 
 
 
C. Substrate scope in 1,6-allylation of dienones. 
A number of dienones with an aromatic ketone and the alkyl group on the d 
carbon participate into this nickel catalyzed allylation (Table 2). This structure 
ensures that high selectivity for 1,6 addition occurs during the allylation reaction. 
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Table 7: Ni-catalyzed conjugate allylation of different substrates to give 1,6 adducts 
 
B(pin) R R
10 mol% Ni(cod)2
10 mol% PCy3
THF, rt, 18 h
3 equiv
R
O
R
O
R
1,6-addition1,2-addition
+
R
 
Entry Substrate Major product Yield 
 
 
 
1 
 
 
Me
O
Ph  
 
Me
O
Ph  
 
 
63 
 
 
2 
 
pentyl
O
Ph
 
 
pentyl
O
Ph  
 
 
55 
 
 
3 
 
Me
O
O
 
Me
O
O
 
 
 
74 
 
 
 
4 
 
Pentyl
O
O
 
 
Pentyl
O
O
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D. Conclusions 
In conclusion, we have discovered a nickel-catalyzed allylation of dienones with 
the pinacol ester of allylboronic acid. The reaction proceeds through a h3 p-allyl 
complex intermediate, which undergoes 3,3’-reductive elimination. We also studied 
the relationship between the dienone structure and 1,2- and 1,6-regioselectvity. We 
developed the 1,2- and 1,6-allylation to give high yield by using 3.0 equivalent 
allylB(pin) and 10 mol % of the catalyst complex. By screening different chiral 
ligands, we also developed the catalyzed asymmetric 1,2 allylation of dienones with 
high enantioselectivity. 
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IV. Experimental section: 
 
      General: 1H NMR spectra were recorded on Gemini-400 (400 MHz) 
spectrometers. Chemical shifts are reported in ppm from tetramethylsilane with the 
solvent resonance as an internal standard (CDCl3: 7.26 ppm). Data are reported as 
follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q 
= quartet, m = multiplet), and coupling constants (Hz). 13C NMR was recorded on a 
Gemini-400 (100 MHz) instrument, or a Gemini-500 (125 MHz) instrument with 
complete proton decoupling. Chemical shifts are reported in ppm from 
tetramethylsilane with the solvent as the internal standard (CDCl3: 77.2 ppm). 
Infrared (IR) spectra were recorded on a Nicolet 210. Low-resolution mass 
spectrometry was obtained by the Boston College, Department of Chemistry Mass 
Spectrometry Facility.  
Liquid chromatography was performed using forced flow (flash 
chromatography) on silica gel (SiO2, 40-63 μm) purchased from Silicycle. Thin layer 
chromatography (TLC) was performed on 250 μm silica gel plates from Silicycle. 
Visualization was obtained by using UV light, phosphomolybdic acid in ethanol, or 
potassium permanganate in water, and then followed by heating. 
Analytical chiral gas-liquid chromatography (GLC) was performed on a 
Hewlett-Packard 6890 series chromatograph equipped with a CTC Analysis Combi 
Pal autosampler by Leap Technologies (Carrboro, NC), a split mode capillary 
injection system, a flame ionization detector, and a Supelco β-dex 120 column with 
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helium as the carrier gas. Analytical achiral GLC was performed on a 
Hewlett-Packard 6890 series chromatograph equipped with a split mode capillary 
injection system, a flame ionization detector, and a Hewlett-Packard Ultra 1 capillary 
column (0.33 μm film thickness, 25 m length, 0.2mm ID) with helium as the carrier 
gas. Analytical chiral supercritical fluid chromatography (SFC) was performed on a 
Berger Instruments supercritical chromatograph equipped with an Alcott autosampler 
and a Knauer UV detector. 
All reactions were conducted in oven or flame dried glassware under an inert 
atmosphere of nitrogen or argon. Toluene, d8-toluene, and d6-benzene were distilled 
over CaH2 and degassed by freeze-pump-thaw cycles prior to use. Anhydrous 
tetrahydrofuran (THF), methylene chloride, and diethyl ether were purified using a 
Pure Solv MD-4 solvent purification system from Innovative Technology Inc. by 
passing the solvent through two activated alumina columns after being purged with Ar. 
Activated dienone substrates used in the 1,2-allylation were synthesized by the Wittig 
reaction and that used in 1,6-allylation were synthesized by the desired Grignard 
reagent to the corresponding aldehyde. Bis(1,5-cyclooctadiene)nickel(0) was 
purchased from Strem Chemical Company. 5-fluoro-2-methylbenzaldehyde was 
purchased from Oakwood Chemicals and used without further purification. All other 
reagents were purchased from either Fisher or Aldrich Chemical Companies and used 
directly. 
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Ligand Synthesis:  
OH
OH
Ph Ph
Ph Ph
H
N
TEA, PCl3
THF
N
21% yield
O
O
O
O O
P
O
Ph Ph
Ph Ph  
2.41 ml (21.4 mmol) of hexamethyleneimine was added to a mixture of 1.0 g 
(2.14 mmol) of diol (synthesized from L-tartaric acid)29 and 4 Å molecular sieves in 
20.0 mL of THF at 0 oC. The solution was warmed up to ambient temperature for 30 
minutes. Next, 0.22 ml (2.57 mmol) of trichlorophosphine was added to the mixture 
dropwise. The reaction was warmed up to room temperature and kept stiring there for 
overnight. Et2O was used to dilute the reaction, and then celite was used to filter the 
solution. The filtration was concentrated under reduced pressure. Column 
chromatography (SiO2, hexanes:EtOAc) gave 0.27 g (21%) of phosphonite ligand as a 
white solid. 
 
1-((3aR,8aR)-2,2-dimethyl-4,4,8,8-tetraphenyl-tetrah
ydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)
azepane. 1H NMR (400 MHz, CDCl3): δ 7.81-7.79 (2H, 
m), 7.65-7.62 (2H, m), 7.49-7.43 (4H, m), 7.34-7.17 (12H, m), 5.21-5.18 (1H, dd, 
J=3.6, 8.4 Hz), 4.78-4.75 (1H, d, J=8.8 Hz), 3.40-3.23 (4H, m), 1.74-1.65 (8H, m), 
1.35 (3H, s), 1.27 (3H, s); 147.41 146.87 142.62 142.12 129.27 128.96 128.17 127.76 
127.65 127.53 127.44 127.35 127.26 127.16 127.12 111.62 82.87 82.64 82.44 81.68  
 
____________________________ 
29 Seebach, D.; Beck, A. K.; Keckel, A. Angew. Chem. Int. Ed. 2001, 40, 92. 
N
O
O O
P
O
Ph Ph
Ph Ph
39 
81.50 81.40 (the region 81.40-82.87 ppm contains extra carbon peaks, due to C-P 
Coupling, see: Boele, M.D.K.; Kamer, P.C.J.; Lutz, M.; Spek, A.L.; de Vries, J.G.; 
van Leeuwen, P.W.N.M.; van Strijdonck, G.P.F. Chem. Eur. J. 2004, 10, 6232) 47.10 
31.54 30.37 27.87 25.54; 31P NMR (300 MHz, CDCl3): 141.7; IR (CH2Cl2): 3063 (w), 
2994 (w), 2926 (m), 2854 (w), 1492 (m), 1446 (m), 1372 (m), 1250 (m), 1214 (m), 
1163 (m), 1083 (m), 1032 (s), 999 (m), 937 (w), 907 (w), 876 (s), 824 (m), 801 (m), 
773 (m), 738 (s), 700 (s), 662 (w), 638 (w), 534 (m) cm-1; LRMS (ESI+) Calc’d for 
C37H41NO4P (M+H)+: 594.27732 Observed (M+H)+: 594.41776. 
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43 
  Representative procedure for the synthesis of dienones: 
Ph
O
Ph3P
O
Ph
OToluene
110oC
80% yield  
In a flame-dried 50 ml vial with a magnetic stir bar, 2.4 g (7.5 mmol) of 
1-(triphenyl phospharanylidene)-2-propanone was diluted by 10.0 mL of toluene 
under nitrogen. 0.95 ml (0.0075 mmol) of trans-cinnamaldehyde was then added 
dropwise into the solution. After that, the vial was capped, taped and stirred under the 
temperature 110oC for 12 hours. Then the reaction was quenched with water and the 
aqueous layer was washed with methylene chloride (3 x 50ml). The organic layers 
were combined and washed with brine and dried with Na2SO4. After volatiles were 
removed, silica gel chromatography (hexanes/ethyl acetate) was used to give 1.04g 
(81% yield) of the desired product. 
(3E,5E)-6-phenylhexa-3,5-dien-2-one. 1H NMR (400 
MHz, CDCl3): δ 7.49-7.26 (6H, m), 6.98-6.94 (1H, d, 
J=15.6 Hz), 6.92-6.85 (1H, dd, J=15.6, 10.0 Hz), 
6.28-6.24 (1H, d, J=15.6 Hz), 6.322 (1H, s)r; 13C NMR (400 MHz, CDCl3): δ 198.5 
143.5 141.4 136.1 130.6 129.4 129.0 127.4 126.8 27.6; IR(neat): 3059 (w), 3027 (w), 
1683 (m), 1667 (s), 1652 (s), 1613 (s), 1587 (s), 1495 (w), 1449 (w), 1424 (w), 1359 
(m), 1314 (w), 1288 (w), 1249 (s), 1178 (w), 1142 (m), 1072 (w), 995 (s), 961 (w), 
814 (w), 750 (s), 691 (s), 638 (w), 562 (w), 519 (w), 502 (w) cm-1; LRMS (ESI+) 
Calc’d for C12H13O (M+H)+: 173.09664 Observed (M+H)+: 173.09640. 
 
O
Me
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(4E,6E)-2-methyl-7-phenylhepta-4,6-dien-3-one. 1H 
NMR (400 MHz, CDCl3): δ 7.48-7.29 (6H, m), 
6.98-6.94 (1H, d, J=15.6 Hz), 6.92-6.86 (1H, dd, J=9.6, 
15.6 Hz), 6.39-6.35 (1H, d, J=15.2 Hz), 2.89-2.83 (1H, m), 1.16-1.15 (6H, d, J=7.2 
Hz); 13C NMR (400 MHz, CDCl3): δ 204.0 142.6 141.3 136.3 129.2 129.0 128.1 
127.3 127.0 39.4 18.8; IR(neat): 3028 (w), 2968 (m), 2931 (w), 2872 (w), 1682 (m), 
1658 (m), 1615 (m), 1586 (s), 1466 (m), 1448 (m), 1383 (m), 1352 (m), 1314 (w), 
1286 (m), 1203 (s), 1151 (m), 1119 (w), 1048 (s), 998 (s), 842 (w), 753 (s), 690 (s), 
506 (w) cm-1; LRMS (ESI+) Calc’d for C14H17O (M+H)+: 201.12794 Observed 
(M+H)+: 201.12841. 
O
47 
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(1E,3E)-1-phenyldeca-1,3-dien-5-one. 1H 
NMR (400 MHz, CDCl3): δ 7.48-7.30 (6H, m), 
6.97-6.94 (2H, d, J=15.2 Hz), 6.91-6.85 (1H, dd, 
J=15.2 Hz), 6.31-6.27 (1H, d, J=15.6 Hz), 2.61-2.57 (2H, t, J=7.2 Hz), 1.69-1.62 (2H, 
m), 1.37-1.27 (4H, m), 0.92-0.89 (3H, t, J=6.8 Hz); 13C NMR (400 MHz, CDCl3): δ 
200.9 142.5 141.2 136.3 129.9 129.3 129.0 127.4 127.0 41.0 31.8 24.4 22.8 14.2; 
IR(neat): 3060 (w), 3028 (w), 3000 (w), 2957 (m), 2930 (m), 2889 (w), 2854 (m), 
1681 (s), 1586 (s), 1486 (m), 1467 (m), 1449 (m), 1406 (m), 1372 (s), 1317 (m), 1280 
(m), 1245 (m), 1216 (m), 1179 (m), 1126 (s), 1073 (s), 1037 (m), 1007 (s), 998 (s), 
959 (w), 924 (w), 884 (w), 851 (w), 811 (w), 757 (w), 746 (s), 722 (m), 688 (s), 617 
(w), 549 (w), 504 (m), 416 (m) cm-1; LRMS (ESI+) Calc’d for C16H21O1 (M+H)+: 
229.15924 Observed (M+H)+: 229.15958. 
O
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(2E,4E)-1-cyclohexyl-5-phenylpenta-2,4-dien-1-one. 
1H NMR (400 MHz, CDCl3): δ 7.48-7.31 (6H, m), 
6.97-6.85 (2H, m), 6.37-6.34 (1H, d, J=15.2 Hz), 
2.61-2.55 (1H, m), 1.88-1.66 (6H, m), 1.45-1.24 (4H, m); 13C NMR (400 MHz, 
CDCl3): δ 203.4, 142.4, 141.2, 136.3, 129.2, 128.9, 128.4, 127.3, 127.0, 49.4, 29.0, 
26.2, 26.0; IR(neat): 3027 (w), 2925 (s), 2852 (s), 1677 (m), 1650 (m), 1614 (w), 
1584 (s), 1447 (m), 1371 (m), 1343 (m), 1315 (m), 1290 (m), 1244 (m), 1192 (m), 
1168 (m), 1141 (m), 1081 (s), 1063 (w), 996 (s), 947 (w), 921 (w), 887 (w), 826 (w), 
793 (w), 751 (s), 690 (s), 506 (m), 394 (w) cm-1; LRMS (ESI+) Calc’d for C17H21O1 
(M+H)+: 241.15924 Observed (M+H)+: 241.15983. 
 
O
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(2E,4E)-1,5-diphenylpenta-2,4-dien-1-one. 1H 
NMR (400 MHz, CDCl3): δ 8.00-7.98 (2H, d, J=6.0 
Hz), 7.65-7.30 (9H, m), 7.12-7.08 (1H, d, J=14.8 Hz), 
7.04-7.02 (2H, m); 13C NMR (400 MHz, CDCl3): δ 190.5 144.9 142.0 138.4 136.3 
132.8 129.4 129.0 128.7 128.5 127.4 127.l 125.6; IR(neat): 3058 (w), 3026 (w), 2918 
(w), 2849 (w), 1655 (s), 1599 (s), 1583 (s), 1573 (s), 1494 (w), 1447 (m), 1351 (s), 
1286 (s), 1250 (s), 1199 (w), 1178 (w), 1150 (m), 1072 (w), 1033 (w), 1015 (s), 998 
(s), 879 (w), 845 (m), 775 (m), 748 (m), 693 (s), 667 (m), 504 (w) cm-1; LRMS (ESI+) 
Calc’d for C17H15O1 (M+H)+: 235.11229 Observed (M+H)+: 235.11257. 
O
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 (3E,5E)-5-methyl-6-phenylhexa-3,5-dien-2-one. 1H 
NMR (400 MHz, CDCl3): δ 7.39-7.30 (6H, m), 6.90 (1H, 
s), 6.28-6.24 (1H, d, J=16.0), 2.35 (3H, s), 2.06 (3H, s); 
13C NMR (400 MHz, CDCl3): δ 198.8, 148.9, 139.9, 136.8, 134.6, 129.6, 128.6, 
128.1, 126.9, 27.8, 14.0; IR(neat): 3050 (w), 3021 (w), 2918 (w), 2861 (w), 1685 (m), 
1665 (s), 1605 (s), 1586 (s), 1490 (w), 1444 (w), 1395 (w), 1359 (s), 1295 (m), 1255 
(s), 1209 (m), 1174 (w), 1078 (m), 1024 (s), 970 (w), 922 (w), 882 (w), 827 (m), 749 
(s), 698 (s), 663 (w), 587 (w), 555 (m), 515 (w), 461 (m); LRMS (ESI+) Calc’d for 
C13H15O1 (M+H)+: 187.11229 Observed (M+H)+: 187.11205. 
O
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(2E,4E)-1-phenyldeca-2,4-dien-1-one. 1H 
NMR (400 MHz, CDCl3): δ 7.94-7.92 (3H, m), 
7.54-7.38 (3H, m), 6.90-6.86 (1H, d, J=14.8) 
6.35-6.22 (2H, m), 2.21-2.18 (2H, m), 1.47-1.31 (6H, m), 0.89-0.88 (3H, m); 13C 
NMR (400 MHz, CDCl3): δ 191.1, 146.8, 145.6 138.5 132.6 129.3 128.6 128.5 123.7 
33.4 31.6 28.6 22.7 14.2; IR(neat): 3059 (w), 3027 (w), 2955 (m), 2926 (s), 2857 (m), 
1661 (s), 1625 (m), 1587 (s), 1447 (m), 1352 (w), 1254 (s), 1211 (w), 1179 (w), 1157 
(R) (w), 1114 (w), 1072 (w), 1034 (w), 1000 (s), 874 (w), 833 (m), 769 (m), 693 (s), 
665 (m), 617 (w) cm-1; LRMS (ESI+) Calc’d for C16H21O1 (M+H)+: 229.15924 
Observed (M+H)+: 229.16025. 
O
62 
 
63 
 
 
 
 
 
64 
Procedure for the synthesis of (2E,4E)-1-(furan-2-yl)hexa-2,4-dien-1-one: 
O H
n-BuLi
Et2O, TMEDA
0oC, 1h
O Li
O
OH
O
MnO2, 2days
O
O
10% overall yield
H
 
In a flame-dried 100 ml round bottom flask with a magnetic stir bar, 3.6 ml 
(50.0 mmol) of furan was diluted by 30.0 ml of diethyl ether under nitrogen. After the 
solution was cooled to 00C, tetramethylethylenediamine (7.6 ml) and n-butyllithium 
(22.0 ml, 2.27M, 50.0 mmol) were then added dropwise into the solution. After that, 
the solution was stirred under the temperature 00C for 1 hours. Then the solution was 
cooled to -780C and trans,trans-2,4-hexadienal (5.4 ml, 50.0 mmol) was added 
dropwise. After 12 hours, the reaction was quenched with water and the aqueous layer 
was washed with methylene chloride (3 x 50ml). The organic layers were combined 
and washed with brine and dried with Na2SO4. After volatiles were removed, it gave 
the crude product, (2E,4E)-1-(furan-2-yl)hexa-2,4-dien-1-ol.  
To another flame-dried 100ml round bottom flask, the crude product 
(2E,4E)-1-(furan-2-yl)hexa-2,4-dien-1-ol, manganese oxide and dichloromethane 
were added under nitrogen. After stirring for another 42 hours, the reaction was 
filtered by celite. After volatiles were removed, silica gel chromatography 
(hexanes/ethyl acetate 20:1) was used to give 0.3 g (10% overall yield) of the desired 
product. 
65 
 
 (2E,4E)-1-(furan-2-yl)hexa-2,4-dien-1-one. 1H NMR 
(400 MHz, CDCl3): δ 7.61-7.60 (1H, m), 7.50-7.43 (1H, m), 
7.26-7.22 (1H, m), 6.79-6.75 (1H, d, J=15.2 Hz), 6.57-6.54 
(1H, m), 6.36-6.23 (2H, m), 1.90-1.89 (3H, d, J=4.0 Hz); 13C NMR (400 MHz, 
CDCl3): δ 178.6 153.9 146.4 144.5 141.5 130.6 122.7 117.2 112.5 19.2; IR(neat): 
3121 (m), 3093 (w), 3015 (w), 2964 (w), 2939 (w), 2914 (w), 2844 (w), 1653 (s), 
1627 (m), 1587 (s), 1557 (w), 1464 (s), 1396 (s), 1341 (m), 1281 (s), 1217 (w), 1162 
(m), 1085 (m), 998 (s), 940 (w), 922 (w), 899 (w), 874 (w), 852 (w), 798 (m), 769 (m), 
726 (w), 704 (w), 594 (w), 543 (w) cm-1; LRMS (ESI+) Calc’d for C10H11O2 (M+H)+: 
163.07590 Observed (M-H2O+H)+: 163.07608. 
O
O
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     Typical procedure for nickel catalyzed allylation of dienone: 
 
.
Ph Me
Ph
HO Me
O
Ph Me
OH
+
B(pin)
E,Z
E,E
THF, 18h, rt
10% metal
10% Ligand
Ph Me
O
+
1,2 addition 1,4 addition
3.0 eq
 
 
To a flame-dried 10 ml vial with a magnetic stir bar, 3.2 mg (0.0116 mmol) of 
bis(1,5-cyclooctadiene)nickel, 3.3 mg (0.0116 mmol) of tricyclohexylphosphine, and 
0.23 mL of THF were added in a glove-box under an argon atmosphere. The vial was 
capped and stirred for 10 min, before adding 58.5 mg (0.348 mmol) of allylboronic 
acid pinacol ester, followed by 26.5 mg (0.116 mmol) of 
(1E,3E)-1-phenyldeca-1,3-dien-5-one. The vial was sealed, removed from the 
glove-box and stirred at room temperature for 18 hours. Then the reaction was 
quenched by water and the aqueous layer was washed with methylene chloride (3 x 
10ml). The organic layers were combined and washed with brine and dried with 
Na2SO4. After volatiles were removed, silica gel chromatography (hexanes/ethyl 
acetate 30:1) was used to give 29.6 mg (95% yield) of the desired product as an oil. 
 
 
69 
(5Z,7E)-4-methyl-8-phenylocta-1,5,7-trien-4-ol. 1H NMR 
(400 MHz, CDCl3): δ 7.74-7.67 (1H, dd, J=15.6, 11.6 Hz) 
7.44-7.20 (5H, m), 6.51-6.47 (1H, d, J=16.0 Hz), 6.18-6.12 
(1H, t, J=11.2 Hz), 5.90-5.85 (1H, m), 5.53-5.50 (1H, d, J=11.6 Hz), 5.21-5.15 (2H, 
m), 2.50-2.33 (2H, m), 1.87 (1H, s), 1.43 (3H, s); 13C NMR (400 MHz, CDCl3): δ 
137.5 136.9 134.2 133.8 129.9 128.7 127.7 126.8 125.8 119.5 74.1 48.8 29.5; 
IR(neat): 3413 (br), 3025 (m), 2923 (m), 2853 (m), 1713 (w), 1459 (m), 1376 (m), 
1260 (w), 1114 (w), 1048 (w), 990 (s), 915 (s), 746 (s), 691 (s) cm-1; LRMS (ESI+) 
Calc’d for C15H17 (M–H2O+H): 197.13303 Observed (M–H2O+H)+: 197.13351. 
HO Me
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 (5E,7E)-4-methyl-8-phenylocta-1,5,7-trien-4-ol. 1H 
NMR (400 MHz, CDCl3): δ 7.40-7.20 (5H, m), 6.81-6.74 
(1H, dd, J=12.0, 16.0 Hz), 6.57-6.53 (1H, d, J=16.0 Hz), 
6.45-6.38 (1H, dd, J=12.0, 16.0 Hz), 5.92-5.88 (1H, d, J=15.2), 5.87-5.77 (1H, m), 
5.19-5.13 (2H, m), 2.43-2.29 (2H, m), 1.35 (3H, s); 13C NMR (400 MHz, CDCl3): δ 
140.6 137.5 133.7 132.4 128.8 128.6 128.2 127.6 126.5 119.5 47.5 30.0 28.2; 
IR(neat): 3413 (br), 3077 (w), 3025 (m), 2957 (m), 2923 (s), 2853 (m), 1713 (w), 
1640 (w), 1493 (w), 1459 (m), 1376 (m), 1260 (w), 1114 (w), 1048 (w), 990 (s), 915 
(s), 746 (s), 691 (s) cm-1; LRMS (ESI+) Calc’d for C15H17 (M–H2O+H)+: 197.13303 
Observed (M–H2O+H)+: 197.13351. 
OH
Me
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 (E)-4-styrylhept-6-en-2-one. 1H NMR (400 MHz, 
CDCl3): δ 7.34-7.18 (5H, m), 6.41-6.37 (1H, d, J=16.0 Hz), 
6.10-6.04 (1H, dd, J=16.0, 8.0 Hz), 5.82-5.71 (1H, m), 
5.08-5.02 (2H, m), 2.91-2.83 (1H, m), 2.62-2.48 (2H, m), 2.24-2.20 (2H, m), 2.14 (3H, 
s); 13C NMR (400 MHz, CDCl3): δ 207.9, 136.1, 132.7, 130.4, 128.7, 127.4, 126.3, 
117.1, 48.5, 39.6, 38.3, 31.0, 30.0; IR(neat): 3078 (w), 3026 (w), 2922 (s), 2852 (m), 
1715 (s), 1640 (w), 1599 (w), 1493 (w), 1448 (m), 1416 (w), 1357 (m), 1287 (m), 
1160 (m), 1126 (w), 1073 (w), 966 (s), 914 (s), 747 (s), 694 (s), 581 (w) cm-1; LRMS 
(ESI+) Calc’d for C15H19O1 (M+H)+: 215.14359 Observed (M+H)+: 215.14466. 
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(5Z,7E)-4-isopropyl-8-phenylocta-1,5,7-trien-4-ol. 1H 
NMR (400 MHz, CDCl3): δ 7.80-7.73 (1H, dd, J=11.2, 
16.2 Hz), 7.43-7.29 (4H, m), 7.27-7.19 (1H, m), 6.49-6.45 
(1H, d, J=15.6 Hz), 6.29-6.23 (1H, t, J=12.0 Hz), 5.92-5.81 (1H, m), 5.40-5.37 (1H, d, 
J=12 Hz), 5.20-5.16 (2H, m), 2.58-2.31 (2H, m), 1.90-1.84 (3H, m), 1.82 (1H, s), 
1.01-0.97 (6H, m); 13C NMR (400 MHz, CDCl3): δ 137.8 134.4 134.1 134.0 131.1 
128.7 127.6 126.7 126.6 119.6 79.3 44.7 37.9 18.0 17.1; IR(neat): 3562 (br), 3075 (w), 
3004 (w), 2962 (s), 2932 (m), 2875 (w), 1709 (w), 1637 (m), 1599 (w), 1493 (m), 
1468 (m), 1448 (m), 1385 (m), 1366 (w), 1272 (w), 1156 (w), 1103 (w), 1071 (w), 
1024 (w), 992 (s), 955 (m), 914 (s), 888 (w), 863 (w), 741 (s), 691 (s), 565 (w), 483 
(w) cm-1; LRMS (ESI+) Calc’d for C17H21 (M–H2O+H)+: 225.16433 Observed 
(M–H2O+H)+: 225.17203. 
HO
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 (5E,7E)-4-isopropyl-8-phenylocta-1,5,7-trien-4-ol. 
1H NMR (400 MHz, CDCl3): δ 7.41-7.29 (4H, m), 
7.23-7.19 (1H, m), 6.84-6.78 (1H, dd, J=15.8, 10.8 Hz), 
6.56-6.52 (1H, d, J=12.0, 16.0 Hz), 6.45-6.38 (1H, dd, J=11.2, 15.6 Hz), 5.86-5.82 
(1H, d, J=16.0 Hz), 5.85-5.74 (1H, m), 5.19-5.13 (2H, m), 2.47-2.29 (2H, m), 
1.84-1.77 (1H, m), 1.67 (1H, s), 0.95-0.93 (6H, m); 13C NMR (400 MHz, CDCl3): δ 
138.1, 137.6, 133.9, 131.9, 129.9, 128.8, 127.5, 126.4, 119.5, 76.8, 43.7, 37.2, 30.0, 
17.9, 17.0; IR(neat): 3569 (br), 3078 (w), 3024 (w), 2960 (s), 2926 (s), 2874 (w), 
2854 (w), 1726 (w), 1639 (w), 1494 (m), 1466 (m), 1448 (m), 1414 (w), 1070 (w), 
1171 (w), 1125 (w), 990 (s), 916 (m), 746 (s), 691 (s) 508 (w) cm-1; LRMS (ESI+) 
Calc’d for C17H21 (M–H2O+H)+: 225.16433 Observed (M–H2O+H)+: 225.16435. 
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(1E,3Z)-5-allyl-1-phenyldeca-1,3-dien-5-ol. 1H 
NMR (400 MHz, CDCl3): δ 7.75-7.68 (1H, m), 
7.44-7.41 (2H, m), 7.33-7.29 (2H, m), 7.24-7.20 
(1H, m), 6.47 (1H, d, J=16.0 Hz), 6.20 (1H, t, J=16.0 Hz), 5.90-5.81 (1H, m), 
5.42-5.39 (1H, d, J=11.6 Hz), 5.19-5.15 (2H, m), 2.49-2.30 (2H, m), 1.84 (1H, s), 
1.66-1.57 (2H, m), 1.44-1.26 (6H, m), 0.90-0.88 (3H, m); 13C NMR (400 MHz, 
CDCl3): δ 137.7 136.0 134.1 133.8 130.4 128.7 127.6 126.8 126.2 119.5 76.8 47.3 
42.3 32.5 23.7 22.9 14.3; IR(neat): 3359 (br), 3076 (w), 3005 (w), 2931 (s), 2859 (m), 
1723 (w), 1638 (w), 1493 (m), 1448 (m), 1377 (m), 1271 (m), 1027 (s), 992 (s), 953 
(m), 913 (m), 740 (s), 691 (s) cm-1; LRMS (ESI+) Calc’d for C19H25 (M–H2O+H)+: 
253.19508 Observed (M–H2O+H)+: 253.20197. 
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(1E,3E)-5-allyl-1-phenyldeca-1,3-dien-5-ol. 1H 
NMR (400 MHz, CDCl3): δ 7.41-7.19 (5H, m), 
6.83-6.76 (1H, dd, J=10.4, 15.6 Hz), 6.56-6.52 
(1H, d, J=16.0 Hz), 6.43-6.37 (1H, dd, J=10.4, 15.2 Hz), 5.85-5.81 (1H, d, J=15.6 Hz), 
5.84-5.75 (1H, m), 5.18-5.13 (2H, m), 2.42-2.27 (2H, m), 1.69 (1H, s), 1.64-1.51 (2H, 
m), 1.37-1.24 (6H, m), 0.90-0.88 (3H, m); 13C NMR (400 MHz, CDCl3): δ 139.9 
137.6 133.7 132.1 128.9 128.8 128.7 127.6 126.5 119.5 74.6 46.1 41.4 32.5 23.5 22.9 
14.3; IR(neat): 3471 (br), 3077 (w), 3024 (w), 2954 (m), 2930 (s), 2858 (m), 1495 (w), 
1448 (w), 1415 (w), 1378 (w), 1296 (w), 1261 (w), 1072 (w), 990 (s), 915 (m), 747 
(s), 692 (s), 505 (w) cm-1; LRMS (ESI+) Calc’d for C19H25 (M-H2O+H)+: 253.19563 
Observed (M-H2O+H)+: 253.22331. 
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 (5Z,7E)-4-cyclohexyl-8-phenylocta-1,5,7-trien-4-ol. 
1H NMR (400 MHz, CDCl3): δ 7.78-7.71 (1H, dd, 
J=11.6, 15.6 Hz), 7.42-7.19 (5H, m), 6.47-6.43 (1H, d, 
J=15.6 Hz), 6.26-6.20 (1H, t, J=11.6 Hz), 5.90-5.80 (1H, m), 5.38-5.35 (1H, d, J=12.0 
Hz), 5.19-5.15 (2H, m), 2.56-2.21 (2H, m), 1.82 (1H, s), 1.97-0.82 (11H, m); 13C 
NMR (400 MHz, CDCl3): δ 137.8 134.9 134.0 130.8 128.7 127.6 126.8 126.7 119.7 
79.1 48.3 44.8 30.0 28.0 27.0 26.8; IR(neat): 3566 (br), 3077 (w), 3024 (w), 2927 (s), 
2852 (m), 1638 (w), 1596 (w), 1495 (w), 1448 (m), 1347 (w), 1261 (w), 1158 (w), 
1071 (w), 992 (s), 915 (m), 814 (w), 747 (m), 692 (m) cm-1; LRMS (ESI+) Calc’d for 
C20H25 (M-H2O+H)+: 265.19563 Observed (M-H2O+H)+: 265.19433.  
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(5E,7E)-4-cyclohexyl-8-phenylocta-1,5,7-trien-4-ol. 
1H NMR (400 MHz, CDCl3): δ 7.40-7.19 (5H, m), 
6.83-6.77 (1H, dd, J=10.4, 15.6 Hz), 6.55-6.51 (1H, d, 
J=15.6 Hz), 6.42-6.36 (1H, dd, J=10.4, 15.2 Hz), 5.85-5.82 (1H, 15.2 Hz), 5.84-5.73 
(1H, m), 5.8 1-5.13 (2H, m), 2.45-2.29 (2H, m), 1.69 (1H, s), 1.90-0.83 (11H, m); 13C 
NMR (400 MHz, CDCl3): δ 138.8, 137.6, 133.9, 131.8, 129.5, 128.8, 128.7, 127.5, 
126.4, 119.6, 117.2, 76.5, 47.6, 43.6, 28.0, 27.0, 26.8; ; IR(neat): 3566 (br), 3077 (w), 
3024 (w), 2927 (s), 2852 (s), 1637 (w), 1595 (w), 1495 (w), 1448 (m), 1347 (w), 1261 
(w), 1158 (w), 1071 (w), 992 (s), 915 (m), 893 (w), 747 (s), 692 (s), 507 (w) cm-1; 
LRMS (ESI+) Calc’d for C20H25 (M-H2O+H)+: 265.19563 Observed (M–H2O+H)+: 
265.19433. 
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(5Z,7E)-4,8-diphenylocta-1,5,7-trien-ol. 1H NMR 
(400 MHz, CDCl3): δ 7.54-7.52 (2H, m), 7.38-7.33 (2H, 
m), 7.30-7.18 (7H, m), 6.45-6.41 (1H, d, J=16.0), 6.23 
(1H, t, J=12.0 Hz), 5.90-5.87 (1H, d, J=12.0 Hz), 5.80-5.69(1H, m), 5.23-5.19 (2H, 
m), 2.74-2.73 (2H, d, J=6.8 Hz), 2.35 (1H, s); 13C NMR (400 MHz, CDCl3): δ 146.9 
137.5 136.0 134.7 133.3 131.1 128.7 128.4 127.8 127.0 126.8 125.8 125.6 120.3 76.7 
49.7; IR(neat): 3559 (br), 3075 (m) 3059 (m), 2919 (m), 2850 (w), 1634 (m), 1600 
(m), 1492 (s), 1448 (s), 1414 (m), 1339 (m), 1276 (m), 1256 (w), 1049 (m), 1027 (s), 
990 (s), 917 (s), 730 (s), 697 (s), 537 (w) cm-1; LRMS (ESI+) Calc’d for C20H19 
(M–H2O+H)+: 259.14868 Observed (M–H2O+H)+: 259.14820. 
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(5E,7E)-4,8-diphenylocta-1,5,7-trien-4-ol. 1H NMR 
(400 MHz, CDCl3): δ 7.49-7.47 (2H, m), 7.38-7.18 
(8H, m), 6.82-6.75 (1H, dd, J=10.4, 15.2 Hz), 
6.56-6.52 (1H, d, J=16.0 Hz), 6.47-6.41 (1H, dd, J=11.2, 16.0 Hz), 6.15-6.11 (1H, d, 
J=15.2 Hz), 5.75-5.64 (1H, m), 5.23-5.17 (2H, m), 2.82-2.70 (2H, m), 2.25 (1H, s); 
13C NMR (400 MHz, CDCl3): 145.5 139.5 137.4 133.3 133.0 129.2 128.8 128.5 
127.7 127.1 126.5 125.6 125.4 120.3 75.8 47.3; IR (neat): 3564 (br), 3060 (w), 3025 
(w), 2923 (s), 2852 (m), 1639 (w), 1597 (w), 1493 (w), 1447 (m), 1350 (w), 1250 (w), 
1158 (w), 1072 (w), 991 (s), 917 (m), 747 (m), 699 (s) cm-1; LRMS (ESI+) Calc’d for 
C20H19 (M-H2O+H)+: 259.14868 Observed (M-H2O+H)+: 259.14865. 
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(E)-1,5-diphenylocta-3,7-dien-1-one. 1H NMR (400 
MHz, CDCl3): δ 7.96-7.89 (2H, m) 7.58-7.53 (1H, m), 
7.48-7.41 (2H, m), 7.36-7.18 (5H, m), 5.83-5.65 (3H, 
m), 5.07-4.93 (2H, m), 3.77-3.68 (2H, m), 3.42-3.37 (1H, m), 2.51-2.44 (2H, m); 13C 
NMR (400 MHz, CDCl3): δ 198.3 (major) 197.9 (minor) 144.2 (major) 144.0 (minor) 
137.7 136.8 (minor) 136.7 (major) 136.4 (minor) 136.1 (major) 133.2 128.7 128.6 
128.5 127.8 (major) 127.6 (minor) 126.4 122.8 (major) 122.0 (minor) 116.6 (minor) 
116.4 (major) 48.9 (major) 44.2 (minor) 42.7 (major) 41.4 (minor) 40.3 (major) 38.0 
(minor); IR (neat): 3061 (w), 3026 (w), 2976 (w), 2922 (m), 2853 (w), 1684 (s), 1639 
(w), 1597 (m), 1580 (w), 1492 (m), 1448 (m), 1401 (w), 1321 (m), 1273 (m), 1207 (s), 
1180 (w), 1158 (w), 1073 (w), 969 (s), 912 (s), 844 (w), 754 (s), 697 (s), 690 (s), 663 
(w), 579 (w), 535 (w) cm-1; LRMS (ESI+) Calc’d for C20H21O1 (M+H)+: 277.15924 
Observed (M+H)+: 277.15951. 
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(5E,7E)-4,7-dimethyl-8-phenylocta-1,5,7-trien-4-ol. 1H 
NMR (400 MHz, CDCl3): δ 7.36-7.20 (5H, m), 6.54 (1H, 
s), 6.46-6.42 (1H, d, J=16.0 Hz), 5.89-5.79 (1H, m), 
5.88-5.84 (1H, d, J=16.0 Hz), 5.19-5.14 (2H, m), 2.41-2.31 (2H, m), 2.00 (3H, s), 
1.73 (1H, s), 1.37 (3H, s); 13C NMR (400 MHz, CDCl3): δ 138.0 135.7 135.2 133.9 
132.9 131.5 129.4 128.3 126.7 119.4 72.5 47.8 28.4 14.3; IR(neat): 3387 (br), 3377 
(w), 3022 (w), 2975 (m), 2925 (s), 2854 (w), 1640 (w), 1598 (w), 1492 (m), 1443 (s), 
1370 (m), 1281 (m), 1236 (w), 968 (s), 916 (s), 825 (m), 747 (s), 699 (s), 508 (w) cm-1; 
LRMS (ESI+) Calc’d for C16H19 (M–H2O+H)+: 211.14868 Observed (M–H2O+H)+: 
211.14915. 
OH
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1H NMR (400 MHz, CDCl3): δ 7.59-7.58 (1H, m), 
7.20-7.19 (1H, m), 6.54-6.53 (1H, m), 5.77-5.70 (1H, m), 
5.65-5.52 (2H, m), 5.00-4.94 (2H, m), 3.54-3.52 (2H, d, 
J=5.6 Hz), 2.30-2.19 (1H, m), 2.13-1.97 (2H, m), 1.00-0.98 (3H, d, J=6.8 Hz); 13C 
NMR (400 MHz, CDCl3): δ 187.6 152.6 146.5 140.5 (major) 139.4 (minor) 137.1 
120.3 (major) 119.5 (minor) 117.5 (major) 117.3 (minor) 116.0 112.4 42.8 (major) 
41.7 (minor) 41.4 (major) 37.8 (minor) 36.7 (major) 20.7 (minor) 20.0 (major); 
IR(neat): 3132 (w), 3076 (w), 2960 (m), 2924 (m), 2871 (w), 1677 (s), 1640 (w), 1568 
(m), 1467 (s), 1439 (w), 1393 (m), 1324 (w), 1290 (m), 1237 (m), 1157 (m), 1084 (m), 
1014 (m), 993 (m), 972 (m), 913 (s), 883 (s), 761 (s), 640 (w), 595 (m) cm-1; LRMS 
(ESI+) Calc’d for C13H17O2 (M+H2O+H)+: 205.12285 Observed (M+H2O+H)+: 
205.12311. 
O
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(E)-5-allyl-1-phenyldec-3-en-1-one. 1H NMR 
(400 MHz, CDCl3): δ 7.98-7.95 (2H, m), 
7.58-7.43 (3H, m), 5.78-5.69 (1H, m), 5.57-5.61 
(1H, m), 5.41-5.34 (1H, m), 4.97-4.92 (2H, m), 3.74-3.69 (2H, m), 2.12-1.99 (1H+2H, 
m), 1.36-1.20 (8H, m), 0.86-0.83 (3H, m); 13C NMR (400 MHz, CDCl3): δ 198.7 
139.0 (major) 137.8 (minor) 137.2 (major) 136.9 (minor) 133.2 (minor) 133.1 (major) 
128.7 128.6 128.5 122.5 (major) 121.4 (minor) 116.0 (minor) 115.8 (major) 42.9 
(minor) 42.8 (major) 40.2(minor) 39.9 (major)  38.3 (minor) 38.1 (major) 35.3 
(minor) 34.6 (major) 32.3 (minor) 32.2 (major) 27.2 (minor) 27.0 (major) 22.9 14.3; 
IR(neat): 3073 (w), 2956 (m), 2925 (s), 2856 (m), 1686 (s), 1639 (w), 1598 (w), 1581 
(w), 1448 (m), 1331 (w), 1274 (m), 1207 (s), 1180 (m), 1073 (w), 991.5 (m), 970 (m), 
911 (m), 750 (m), 732 (w), 690 (s), 663 (w), 597 (w), 574 (w) cm-1; LRMS (ESI+) 
Calc’d for C19H27O1 (M+H)+: 271.20619 Observed (M+H)+: 271.20650.  
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